279 related articles for article (PubMed ID: 30582439)
21. Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca.
Yritia M; Riba J; Ortuño J; Ramirez A; Castillo A; Alfaro Y; de la Torre R; Barbanoj MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):271-81. PubMed ID: 12361741
[TBL] [Abstract][Full Text] [Related]
22. Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.
Gable RS
Addiction; 2007 Jan; 102(1):24-34. PubMed ID: 17207120
[TBL] [Abstract][Full Text] [Related]
23. Determination of Tryptamines and β-Carbolines in Ayahuasca Beverage Consumed During Brazilian Religious Ceremonies.
Santos MC; Navickiene S; Gaujac A
J AOAC Int; 2017 May; 100(3):820-824. PubMed ID: 28105971
[TBL] [Abstract][Full Text] [Related]
24. Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans.
Nunes AA; Dos Santos RG; Osório FL; Sanches RF; Crippa JA; Hallak JE
J Psychoactive Drugs; 2016; 48(3):195-205. PubMed ID: 27230395
[TBL] [Abstract][Full Text] [Related]
25. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP
J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158
[TBL] [Abstract][Full Text] [Related]
26. Ayahuasca: What Healthcare Providers Need to Know.
Goldin D; Salani D
J Addict Nurs; 2021 Apr-Jun 01; 32(2):167-173. PubMed ID: 34060770
[TBL] [Abstract][Full Text] [Related]
27. Various alkaloid profiles in decoctions of Banisteriopsis caapi.
Callaway JC
J Psychoactive Drugs; 2005 Jun; 37(2):151-5. PubMed ID: 16149328
[TBL] [Abstract][Full Text] [Related]
28. Chemical Composition of Traditional and Analog Ayahuasca.
Kaasik H; Souza RCZ; Zandonadi FS; Tófoli LF; Sussulini A
J Psychoactive Drugs; 2021; 53(1):65-75. PubMed ID: 32896230
[TBL] [Abstract][Full Text] [Related]
29. Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture.
Freedland CS; Mansbach RS
Drug Alcohol Depend; 1999 May; 54(3):183-94. PubMed ID: 10372792
[TBL] [Abstract][Full Text] [Related]
30. Ayahuasca for the Treatment of Depression.
Palhano-Fontes F; Soares BL; Galvão-Coelho NL; Arcoverde E; Araujo DB
Curr Top Behav Neurosci; 2022; 56():113-124. PubMed ID: 34761362
[TBL] [Abstract][Full Text] [Related]
31. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease.
Katchborian-Neto A; Santos WT; Nicácio KJ; Corrêa JOA; Murgu M; Martins TMM; Gomes DA; Goes AM; Soares MG; Dias DF; Chagas-Paula DA; Paula ACC
J Ethnopharmacol; 2020 Jun; 255():112743. PubMed ID: 32171895
[TBL] [Abstract][Full Text] [Related]
32. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
[TBL] [Abstract][Full Text] [Related]
33. Ayahuasca Alters Structural Parameters of the Rat Aorta.
Pitol DL; Siéssere S; Dos Santos RG; Rosa ML; Hallak JE; Scalize PH; Pereira BF; Iyomasa MM; Semprini M; Riba J; Regalo SC
J Cardiovasc Pharmacol; 2015 Jul; 66(1):58-62. PubMed ID: 25714595
[TBL] [Abstract][Full Text] [Related]
34. Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.
Pic-Taylor A; da Motta LG; de Morais JA; Junior WM; Santos Ade F; Campos LA; Mortari MR; von Zuben MV; Caldas ED
Behav Processes; 2015 Sep; 118():102-10. PubMed ID: 26049017
[TBL] [Abstract][Full Text] [Related]
35. Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives.
Labate BC
J Psychoactive Drugs; 2011; 43(1):27-35. PubMed ID: 21615005
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Cytotoxicity of Ayahuasca Beverages.
Simão AY; Gonçalves J; Gradillas A; García A; Restolho J; Fernández N; Rodilla JM; Barroso M; Duarte AP; Cristóvão AC; Gallardo E
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260723
[TBL] [Abstract][Full Text] [Related]
37. New Insights into the Chemical Composition of Ayahuasca.
Rodríguez L; López A; Moyna G; Seoane GA; Davyt D; Vázquez Á; Hernández G; Carrera I
ACS Omega; 2022 Apr; 7(14):12307-12317. PubMed ID: 35449956
[TBL] [Abstract][Full Text] [Related]
38. The globalization of ayahuasca: harm reduction or benefit maximization?
Tupper KW
Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
[TBL] [Abstract][Full Text] [Related]
39. Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats.
Favaro VM; Yonamine M; Soares JC; Oliveira MG
PLoS One; 2015; 10(12):e0145840. PubMed ID: 26716991
[TBL] [Abstract][Full Text] [Related]
40. Investigation of Ayahuasca β-Carboline Alkaloids and Tryptamine in Sweat Samples from Religious Community Participants by GC-MS.
Tavares L; Monedeiro F; Bordin DM; De Martinis BS
J Anal Toxicol; 2020 Jul; 44(6):601-609. PubMed ID: 32103256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
